Highlights Waverley Pharma Inc.

Equities

WAVE

CA94357L1058

Market Closed - Toronto S.E. Other stock markets 14:30:00 30/05/2024 BST			5-day change	1st Jan Change
0.025 ^CAD	-.--%		+25.00%	-.--%

04-30	Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Waverley Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Waverley Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-27	CI
Waverley Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	16/08/23	CI
Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/05/23	CI
Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/04/23	CI
Waverley Pharma Provides Business Update	20/03/23	MT
Waverley Pharma Inc. Provides Update on its PARP-1 Inhibitor Program	11/01/23	CI
Waverley Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/11/22	CI
Waverley Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	26/08/22	CI
Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	30/05/22	CI
Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	30/04/22	CI
Waverley Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	26/11/21	CI
Waverley Pharma Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	26/08/21	CI
Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	25/05/21	CI
Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	26/04/21	CI
Waverley Pharma : Awarded 2-Year Tender For Oncology Drug With NHS Scotland	18/01/21	MT
Waverley Pharma Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	26/11/20	CI
Waverley Pharma : Says U.S. Gives Tentative Approval For Pemetrexed Abbreviated New Drug Application	12/11/20	MT
Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United States	12/11/20	CI
Waverley Pharma Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	24/08/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Waverley Pharma Inc.

Equities

WAVE

CA94357L1058

Highlights

Filters